Marshall Wace, LLP Reviva Pharmaceuticals Holdings, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 34,868 shares of RVPH stock, worth $44,631. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,868
Previous 39,100
10.82%
Holding current value
$44,631
Previous $201,000
34.83%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RVPH
# of Institutions
32Shares Held
5.55MCall Options Held
350KPut Options Held
97.8K-
Woodline Partners LP San Francisco, CA1.06MShares$1.35 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1MShares$1.28 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny855KShares$1.09 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY827KShares$1.06 Million0.02% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT504KShares$644,9330.26% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $26.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...